OWLT.NYSEOwlet, INC

Form 4: Eclipse Group Entities Report Owlet Inc. Transactions: Acquisition of Convertible Preferred Stock and Common Stock Warrants

Sentiment:

SEC Form 4


Eclipse-affiliated entities, including Eclipse Early Growth Fund I, L.P., acquired Series B Convertible Preferred Stock and Common Stock Warrants of Owlet, Inc., as reported in a Form 4 filing.

Summary

  • This Form 4 filing details changes in beneficial ownership of Owlet, Inc. securities by several Eclipse-affiliated entities.
  • Eclipse Early Growth Fund I, L.P. acquired 6,000 shares of Series B Convertible Preferred Stock, which are convertible into 777,957 shares of Class A Common Stock.
  • The conversion rate is initially 129.6596 shares of Common Stock per share of Series B Convertible Preferred Stock, subject to adjustment.
  • Eclipse Early Growth Fund I, L.P. also acquired 1,166,935 Common Stock Warrants with an exercise price of $7.7125, expiring on March 1, 2029.
  • The filing also reports indirect ownership of 968,694 and 1,066,472 shares of Class A Common Stock by Eclipse Ventures Fund I, L.P. and Eclipse Continuity Fund I, L.P., respectively.
  • Lior Susan, as the managing member of the general partners of these funds, may be deemed to have voting and dispositive power over these shares.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the filing indicates investment activity by a venture capital firm, suggesting confidence in the company's prospects. However, it's a routine filing, so the impact is limited.

Positives

  • The investment by Eclipse Early Growth Fund I, L.P. signals confidence in Owlet, Inc.'s future prospects.
  • The acquisition of convertible preferred stock provides Owlet with additional capital.
  • The acquisition of warrants provides Owlet with potential future capital.

Risks

  • The exercise price and number of shares issuable upon exercise of the warrants are subject to adjustment, which could impact the value of the warrants.
  • The conversion rate of the preferred stock is also subject to adjustment, potentially affecting the number of common shares received upon conversion.

Future Outlook

The document does not contain explicit forward-looking statements, but the acquisition of securities suggests a positive outlook from the investors.

Industry Context

Venture capital firms like Eclipse are actively investing in growth-stage companies, particularly in sectors like consumer technology and healthcare, which aligns with Owlet's focus on baby monitoring products.

Comparison to Industry Standards

  • Comparable companies in the consumer technology space often receive funding through convertible preferred stock and warrants.
  • The specific terms of the conversion rate and warrant exercise price would need to be compared to similar deals to assess their favorability.
  • Other companies in the baby tech space, such as Nanit, have also attracted significant venture capital investment.

Stakeholder Impact

  • Shareholders may view the investment positively as it provides additional capital to the company.
  • Employees may see it as a sign of stability and growth potential.
  • Customers may benefit from the continued development and improvement of Owlet's products.

Key Dates

DateDescription
02/25/2024Date of the Investment Agreement between Owlet, Inc. and Eclipse Early Growth Fund I, L.P., amongst others.
02/29/2024Date of the transactions: acquisition of Series B Convertible Preferred Stock and Common Stock Warrants.
02/29/2024Date of the Warrant to Purchase Shares of Common Stock of Owlet, Inc.
03/01/2029Expiration date of the Common Stock Warrants.
03/04/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.